[1]
Wesołowski, P., Budzeń, K., Bąk, S., Sygacz, O. and Stachura, T. 2022. Cardiotoxicity of doxorubicin – causes, prevention, prospects. Journal of Education, Health and Sport. 12, 11 (Nov. 2022), 272–277. DOI:https://doi.org/10.12775/JEHS.2022.12.11.035.